5 Reasons to Follow Our Coverage of #NACFC2016

October brings the annual North American Cystic Fibrosis Conference (NACFC), and this year the 30th annual event will be staged in Orlando, Fla. Cystic Fibrosis News Today will offer daily follow-up coverage of the NACFC, which is expected to draw medical professionals, scientists, and other delegates who work in the cystic fibrosis field all over the world.

Here are some of the reasons you should follow our coverage of the event (or attend if you can!):

1. Share knowledge with other CF healthcare professionals

NACFC16 will play host to some of the world’s most renown doctors, researchers and healthcare providers in the world, talking about the current and future stance on cystic fibrosis. The event will be a chance to meet some of these and network with some of the sharpest minds in the field.

Find out more about the 30th North American Cystic Fibrosis Conference in Florida.

2. Receive state-of-the-art medical education on cystic fibrosis

Following our coverage of the 30th North American Cystic Fibrosis Conference will be an excellent way to learn about the latest, treatments, services and products for the care of cystic fibrosis patients.

Promising data on inhaled antifungal therapy to be presented at NACFC16.

3. Attend special classes and short courses

If you’re lucky enough to be there in real life, the day before the conference begins will be dedicated to short courses and special classes for new healthcare professionals and those moving into the field of cystic fibrosis.

Learn more about the special classes and short courses available at NACFC16.

4. A chance to be interactive

With the NACFC16 mobile app, you will be able to take part in live Q&A sessions as well as contribute to polls in session.

Learn more about the #NACFC App here. 

5. Stay up to date with all the latest CF news

Whether you are a CF patient, caregiver or healthcare professional, attending the event or following our coverage of NACFC16 will mean you’ll stay up to date with the very latest information on clinical trials and research data.

Proteostasis to present data from phase 1 study of potential CF therapy at NACFC16.

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.